For this greenfield project, Boccard carried out the entire project with a “global contractor” approach, thus integrating civil engineering, clean rooms, as well as all production units.

This company turned to Boccard for the piping package for its new microcrystalline cellulose (MCC) plant.

As part of a technology transfer between the French and Brazilian laboratory, Boccard was chosen as the supplier of the process equipment.

To increase its production capacity for plasma-derived drugs, LFB called on Boccard Health & Care.

Boccard carried out the design, manufacture, qualification and commissioning of a fermentation platform with a capacity of 1000L.

Boccard undertook the project to design and build a turnkey workshop fro injectables for a major player in the pharmaceutical markets

Boccard carried out the studies and designed the manufacturing process for human vaccines against pertussis, diphtheria and botulism.

Boccard was chosen for its expertise in monoclonal antibodies and disinfection as well as for its know-how in GMP design (good manufacturing practices).

Our teams have designed, manufactured, qualified and commissioned the key equipment for the largest blood fractionation plant in Canada of this Korean group.